The United States microcarriers market holds the largest share within North America, supported by extensive biopharmaceutical manufacturing activity and increasing investment in advanced cell-based therapies. Rising demand for vaccines, monoclonal antibodies, and regenerative medicine products is significantly boosting the adoption of microcarrier technology in large-scale cell culture...